SACK1A and cancer: Previous studies have shown that FAM83A is aberrantly expressed in several human cancers including pancreatic, lung, breast, testis and bladder cancers (23, 25–29) indicating that FAM83A could possibly play an oncogenic role during the development and progression cancer.